Inventor
NAN FAJUN
CN26 patents
⚠️ This page may combine multiple inventors who share the name “NAN FAJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHANGHAI INST MATERIA MEDICA CAS
9 patentsUS11192916B2Dec 7, 2021
Pentacyclic triterpene compound and preparation method therefor, and pharmaceutical composition and use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations58
US10414713B2Sep 17, 2019
Fatty acid compound, preparation method therefor and use therefor
SHANGHAI INST MATERIA MEDICA CAS0 citations49
US11098071B2Aug 24, 2021
GPR84 receptor antagonist and use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations48
US10316008B2Jun 11, 2019
KCNQ potassium channel agonist, and preparation method therefor and use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations45
US10077245B2Sep 18, 2018
KCNQ potassium channel agonists, method of preparation and method of use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations45
US10766889B2Sep 8, 2020
Aryl-2,2′-tandem bisthiazole compound and preparation method and use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations39
US10196389B2Feb 5, 2019
One class of pyrazolone compounds and use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations38
US10278962B2May 7, 2019
Tricyclic analogues, preparation method and uses thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations36
US9643941B2May 9, 2017
2,2′-tandem dithiazole compound, preparation method therefor, and use thereof
SHANGHAI INST MATERIA MEDICA CAS0 citations36
NAN FAJUN
7 patentsUS8455510B2Jun 4, 2013
Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof
NAN FAJUN47 citations91
US8653115B2Feb 18, 2014
Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
NAN FAJUN5 citations70
US8247549B2Aug 21, 2012
Method for preparing 4-(6-amino-purin-9-YL)-2(S)-hydroxy-butyric acid methyl ester
NAN FAJUN2 citations61
US9216962B2Dec 22, 2015
Thiazole compounds, methods for preparation and use thereof
NAN FAJUN3 citations59
US8426606B2Apr 23, 2013
2′,2-bisthiazole non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
NAN FAJUN0 citations50
US8183383B2May 22, 2012
Protein tyrosine phosphatase 1B inhibitor, preparation methods and uses thereof
NAN FAJUN0 citations41
US8470763B2Jun 25, 2013
Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof
NAN FAJUN0 citations35
SHANGHAI INST MATERIA MEDICA
5 patentsUS7741348B2Jun 22, 2010
Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds
SHANGHAI INST MATERIA MEDICA12 citations80
US9353048B2May 31, 2016
Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof
SHANGHAI INST MATERIA MEDICA6 citations68
US7838682B2Nov 23, 2010
Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
SHANGHAI INST MATERIA MEDICA2 citations60
US8039492B2Oct 18, 2011
Substituted cyclic compound, its preparation process and its medical use
SHANGHAI INST MATERIA MEDICA0 citations40
US7683073B2Mar 23, 2010
Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof
SHANGHAI INST MATERIA MEDICA0 citations40
UNIV GEORGETOWN
3 patentsUS6528499B1Mar 4, 2003
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
UNIV GEORGETOWN154 citations98
US7381745B2Jun 3, 2008
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
UNIV GEORGETOWN60 citations97
US6479470B1Nov 12, 2002
Ligands for metabotropic glutamate receptors and inhibitors of NAALAdase
UNIV GEORGETOWN97 citations97